EcoR1 Capital, LLC's Form 4 filing
Tango Therapeutics, Inc. (TNGX) · filed Nov 8, 2024
- Accession no.
- 0000935836-24-000649
- Filed
- Nov 8, 2024
- Trade date
- Nov 6-7, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $8.45M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| EcoR1 Capital, LLCCIK 0001587114 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2024 | Common Stock | SSaleDisposed | −1,494,558 | $3.28 | −$4,902,150.24 | 11,836,178 | Indirect | |
| Nov 7, 2024 | Common Stock | SSaleDisposed | −62,318 | $3.29 | −$205,026.22 | 11,773,860 | Indirect | |
| Nov 7, 2024 | Common Stock | SSaleDisposed | −1,143,124 | $2.92 | −$3,337,922.08 | 10,630,736 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.